Key facts
- Notable investors include Fowler GSIC, FuturizeU.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for MariTest
- ·The full record, as it builds
Funding rounds
No funding rounds for MariTest are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MariTest
Developer of a diagnostic health platform designed for disease detection purposes. The company's platform incorporates non-invasive detection methods, real-time data monitoring, and technology-driven diagnostics, enabling healthcare providers to improve early malaria identification, support timely treatment interventions, and reduce the disease burden in underserved communities.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2022
- Employees
- 9
- Website
- maritestafrica.com/
- Ownership
- Privately Held (backing)
MariTest doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MariTest shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MariTest in its N-PORT filings yet. We sweep new filings monthly.